Novo Nordisk Foundation
Investigator Initiated Clinical Trials
14:00 Copenhagen time
Last verified:
The Novo Nordisk Foundation Investigator Initiated Clinical Trials grant funds larger non-commercial clinical trials in Denmark with budgets of DKK 6-22 million over 3-5 years. The call targets established and mid-career research leaders (Associate Professor or Professor level) based at Danish institutions, running patient-centred trials evaluating new medicines and technologies. This is a single-stage annual call with an August deadline.
Details
| Funder | Novo Nordisk Foundation |
| Budget | DKK 6–22 million per grant |
| Deadline | 18 August 2026 |
| Duration | 3–5 years |
| Consortium | No |
| Application | Single stage |
| Frequency | Annual |
| Next round | 2027-06 |
| Eligible countries | DK |
Eligibility & scope
Supports larger non-commercial clinical trials (monocentric or multicenter) anchored at a Danish hospital. Main applicant must be based in Denmark. International trials coordinated outside Denmark may apply for the Danish portion only. Trials must conform to GCP guidelines. Open to mid-career and established research leaders in clinical medicine.
Who Should Apply
- •Associate Professors and Professors leading independent research groups
- •Researchers based at Danish academic or hospital institutions
- •Non-commercial clinical trial projects evaluating medicines or medical technology
- •Researchers with established track records in patient-centred clinical research
Key Dates
- •Deadline 18 August 2026, 14:00 Copenhagen time
- •Single-stage application and review
- •3-5 year project duration
Tips for Applicants
- ✓Emphasise the non-commercial, patient-benefit angle, this funder explicitly excludes industry-sponsored trials and prioritises clinical improvements.
- ✓Include clear endpoints and feasibility data; clinical trials require robust methodology justification given the budget and scale.
- ✓Secure institutional support letters from your host hospital or university, this grant demands dedicated infrastructure and patient recruitment capacity.
Frequently Asked Questions
How much funding is available for an investigator-initiated clinical trial?
Grants range from DKK 6 million to DKK 22 million per project.
Who is eligible for the Novo Nordisk Foundation Investigator Initiated Clinical Trials grant?
Established and mid-career research leaders at Associate Professor or Professor level based at Danish institutions.
How long can an investigator-initiated clinical trial run?
Project duration is 3 to 5 years.
Can commercial companies sponsor an investigator-initiated trial funded by Novo Nordisk?
No, the grant supports non-commercial trials only, aimed at improving patient treatment through new medicine and technology.
When is the next deadline for this grant?
The next expected round opens in June 2027; this call recurs annually.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
More from Novo Nordisk Foundation
Novo Nordisk Foundation Data Science Investigator Programme 2026
Deadline: 15 Jul 2026Up to DKK 14.7M (~€1.97M)Data Science Investigator Programme 2026
Deadline: 15 Jul 2026Up to DKK 14.7 million per grantNexa innovation call: Innovations that reduce the impact of heat on people living with cardiometabolic diseases in Africa
Deadline: 22 Jul 2026Novonesis Biotechnology Prize
Deadline: 1 Aug 20265 Million DKKRECRUIT Sabbatical Grants, Autumn 2026
Deadline: 12 Aug 2026Up to DKK 1 million per grant
Browse Related
Could Investigator Initiated Clinical Trials be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →